Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Critical Reviews in Oral Biology & Medicine
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Weinberg, W. C.
Right arrow Articles by Denning, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
13(6):453-464 (2002)     Crit Rev Oral Biol Med
© 2002 International and American Associations for Dental Research

P21WAF1 CONTROL OF EPITHELIAL CELL CYCLE AND CELL FATE

Wendy C. Weinberg1,* and Mitchell F. Denning2

1 Laboratory of Immunobiology, Division of Monoclonal Antibodies, Center for Biologics Evaluation and Research, FDA, NIH Bldg. 29B, Room 3NN04, HFM-564, Bethesda, MD 20892; and
2 Department of Pathology and the Cardinal Bernardin Cancer Center, Loyola University Medical Center, 2160 S. First Avenue, Maywood, IL 60153;

Correspondence: *corresponding author, DMA/CBER/FDA, 29 Lincoln Drive, Bldg. 29B/Room 3NN04, HFM-564, Bethesda, MD 20892-4555, weinberg{at}cber.fda.gov

As a broad-acting cyclin-dependent kinase inhibitor, p21WAF1 occupies a central position in the cell cycle regulation of self-renewing tissues such as oral mucosa and skin. In addition to regulating normal cell cycle progression decisions, p21WAF1 integrates genotoxic insults into growth arrest and apoptotic signaling pathways that ultimately determine cell fate. As a result of its complex interactions with cell cycle machinery and response to mutagenic agents, p21WAF1 also has stage-specific roles in epithelial carcinogenesis. Finally, a view is emerging of p21WAF1 as not merely a cyclin-dependent kinase inhibitor, but also as a direct participant in regulating genes involved in growth arrest, senescence, and aging, thus providing an additional layer of control over matters of the cell cycle. This review discusses these various roles played by p21WAF1 in cell cycle control, and attempts to relate these to epithelial cell biology, with special emphasis on keratinocytes. (Abbreviations used include the following: Brdu, 5-Bromo-2-deoxyuridine; cdk, cyclin-dependent kinase; EGF, epidermal growth factor; KIP, kinase inhibitor protein; PCNA, proliferating cell nuclear antigen; and TPA, 12-O-tetradecanoylphorbol-13-acetate.)

Key Words: p21WAF1 • cell cycle • keratinocytes • cyclin-dependent kinase • cell transformation

Critical Reviews in Oral Biology & Medicine, Vol. 13, No. 6, 453-464 (2002)
DOI: 10.1177/154411130201300603
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 EndocrinologyHome page
V. Chesnokova, C. Wong, S. Zonis, A. Gruszka, K. Wawrowsky, S.-G. Ren, A. BenShlomo, and R. Yu
Diminished Pancreatic {beta}-Cell Mass in Securin-Null Mice Is Caused by {beta}-Cell Apoptosis and Senescence
Endocrinology, June 1, 2009; 150(6): 2603 - 2610.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. F. Calvisi, H. Donninger, M. D. Vos, M. J. Birrer, L. Gordon, V. Leaner, and G. J. Clark
NORE1A Tumor Suppressor Candidate Modulates p21CIP1 via p53
Cancer Res., June 1, 2009; 69(11): 4629 - 4637.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
W. W. Hwang-Verslues and F. M. Sladek
Nuclear Receptor Hepatocyte Nuclear Factor 4{alpha}1 Competes with Oncoprotein c-Myc for Control of the p21/WAF1 Promoter
Mol. Endocrinol., January 1, 2008; 22(1): 78 - 90.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K.-M. Bae, H. Wang, G. Jiang, M. G. Chen, L. Lu, and L. Xiao
Protein Kinase C{varepsilon} Is Overexpressed in Primary Human Non-Small Cell Lung Cancers and Functionally Required for Proliferation of Non-Small Cell Lung Cancer Cells in a p21/Cip1-Dependent Manner
Cancer Res., July 1, 2007; 67(13): 6053 - 6063.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
H. E. van Gijssel, T. A. Leil, W. C. Weinberg, R. L. Divi, O. A. Olivero, and M. C. Poirier
Cisplatin-DNA damage in p21WAF1/Cip1 deficient mouse keratinocytes exposed to cisplatin
Mutagenesis, January 1, 2007; 22(1): 49 - 54.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. Ueda, K. Fukamachi, Y. Matsuoka, N. Takasuka, F. Takeshita, A. Naito, M. Iigo, D. B. Alexander, M. A. Moore, I. Saito, et al.
Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas
Carcinogenesis, December 1, 2006; 27(12): 2497 - 2510.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
A. Hrzenjak, F. Moinfar, M.-L. Kremser, B. Strohmeier, P. B. Staber, K. Zatloukal, and H. Denk
Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells.
Mol. Cancer Ther., September 1, 2006; 5(9): 2203 - 2210.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
T. Oskarsson, M. A. G. Essers, N. Dubois, S. Offner, C. Dubey, C. Roger, D. Metzger, P. Chambon, E. Hummler, P. Beard, et al.
Skin epidermis lacking the c-myc gene is resistant to Ras-driven tumorigenesis but can reacquire sensitivity upon additional loss of the p21Cip1 gene
Genes & Dev., August 1, 2006; 20(15): 2024 - 2029.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
K.E. King, R.M. Ponnamperuma, M.J. Gerdes, T. Tokino, T. Yamashita, C.C. Baker, and W.C. Weinberg
Unique domain functions of p63 isotypes that differentially regulate distinct aspects of epidermal homeostasis
Carcinogenesis, January 1, 2006; 27(1): 53 - 63.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
K. A. Nath
Provenance of the protective property of p21
Am J Physiol Renal Physiol, September 1, 2005; 289(3): F512 - F513.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
A. K. Khanna, M. Plummer, V. Nilakantan, and G. M. Pieper
Recombinant p21 Protein Inhibits Lymphocyte Proliferation and Transcription Factors
J. Immunol., June 15, 2005; 174(12): 7610 - 7617.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Robitaille, R. Proulx, K. Robitaille, R. Blouin, and L. Germain
The Mitogen-activated Protein Kinase Kinase Kinase Dual Leucine Zipper-bearing Kinase (DLK) Acts as a Key Regulator of Keratinocyte Terminal Differentiation
J. Biol. Chem., April 1, 2005; 280(13): 12732 - 12741.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Chen, J. Turner, S. McCarthy, M. Scaltriti, S. Bettuzzi, and T. J. Yeatman
Clusterin-Mediated Apoptosis Is Regulated by Adenomatous Polyposis Coli and Is p21 Dependent but p53 Independent
Cancer Res., October 15, 2004; 64(20): 7412 - 7419.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
L. Gonzalez-Michaca, G. Farrugia, A. J. Croatt, J. Alam, and K. A. Nath
Heme: a determinant of life and death in renal tubular epithelial cells
Am J Physiol Renal Physiol, February 1, 2004; 286(2): F370 - F377.
[Abstract] [Full Text] [PDF]